Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 32, 2008 - Issue 6
142
Views
24
CrossRef citations to date
0
Altmetric
Original Article

α-Thalassemia Mutations in Khuzestan Province, Southwest Iran

, , , , , , , , & show all
Pages 546-552 | Received 01 Jun 2008, Accepted 27 Jul 2008, Published online: 07 Jul 2009
 

Abstract

Although α-thalassemia (α-thal) is the most common hereditary hemoglobin (Hb) disorder in Iran, no comprehensive data are so far available on the prevalence of the disease in the province of Khuzestan in Southwest Iran. This study investigates the spectrum of α-thal mutations in this region.

One hundred and twenty-one subjects from Khuzestan Province, Iran, were initially tested for the three most common Iranian α-thal mutations ( − α3.7, − α4.2, and − − MED) by gap-polymerase chain reaction (gap-PCR). Reverse hybridization test strips and DNA sequencing were used to identify additional α-globin mutations. A total of 131 mutated α-globin alleles were identified in these patients. Of the 13 mutations that were detected in Khuzestan Province, Iran, the − α3.7 single gene deletion was the most frequently identified variant, representing 62.6% of the total; we also observed significant numbers of individuals with compound heterozygous mutations. On the basis of our results, we strongly recommend screening for the most common mutations to improve the molecular diagnosis of anemia in this region.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.